Sanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial Results
GlobeNewswire News Room· 2025-08-04 21:00
Company Overview - Sanuwave Health, Inc. is a leading provider of next-generation FDA-approved wound care products focused on research, development, and commercialization of patented, non-invasive medical systems for tissue repair and regeneration [1][2][3] - The company applies its patented energy transfer technologies in various medical fields including wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions [3] Financial Results Announcement - Sanuwave will host a live conference call on August 8, 2025, at 8:30 AM (ET) to present its Q2 2025 financial results [1] - Access to the call can be made via toll-free and international numbers, with a specific conference ID provided for participants [1] Replay Information - A replay of the conference call will be available until August 29, 2025, with specific toll-free and international numbers for access [2]
EverQuote (EVER) Q2 EPS Jumps 129%
The Motley Fool· 2025-08-04 20:58
EverQuote (EVER 6.89%), an online insurance marketplace known for its AI-driven data platform, reported its second quarter 2025 results on August 4, 2025. The company announced GAAP EPS of $0.39, beating analyst estimates of $0.35 (GAAP), while GAAP revenue reached $156.6 million, just below the GAAP consensus of $157.2 million. These results reflect strong profitability and operational efficiency even as growth rates are beginning to moderate compared to earlier quarters. Overall, the period saw robust gai ...
Tariff Uncertainty Helps Drive Down Berkshire Hathaway Profits
PYMNTS.com· 2025-08-04 20:55
Company Performance - Berkshire Hathaway's shares fell over 3% following a quarterly profit drop [1] - The firm reported a 4% decline in operating income, down to $11.6 billion from the previous year, attributed to reduced underwriting premiums and trade policy uncertainties [3] - A significant $3.8 billion write-down was recorded for its 27.4% stake in Kraft Heinz, marking the second write-down since a $3 billion write-down in 2019 [2] Investment Strategy - The company has ceased increasing its cash reserves, ending an eleven-quarter streak that began in Q3 2022 [4] - Berkshire Hathaway has not repurchased any shares since May 2024, indicating caution regarding market valuations amid ongoing economic uncertainties [3] Market Trends - Kraft Heinz, a significant part of Berkshire's portfolio, has faced challenges as consumers shift towards healthier options and private-label products [4] - The rise of private-label brands is driven by major retailers expanding their offerings and economic pressures prompting consumers to seek cost-effective alternatives [6]
Amazon Stock: Cheap Given Its Growth Prospects
Seeking Alpha· 2025-08-04 20:54
Group 1 - Amazon.com, Inc. reported better-than-expected earnings for its second fiscal quarter, driven by strong performance in Amazon Web Services and North American e-Commerce [1] - The company continues to experience robust growth, indicating a positive trend in its business operations [1]
Axon Enterprise Stock Climbs After Q2 Results: Here's Why
Benzinga· 2025-08-04 20:54
Core Insights - Axon Enterprise reported strong second-quarter results, with earnings of $2.12 per share, exceeding analyst expectations by 45.11% [1] - Quarterly revenue reached $669 million, surpassing the consensus estimate of $641.24 million and showing a significant increase from $504.1 million in the same quarter last year [1] Financial Performance - Software & Services revenue grew 39% year-over-year to $292 million [4] - Annual recurring revenue increased by 39% to $1.2 billion [4] - Connected Devices revenue rose 29% year-over-year to $376 million [4] - Platform Solutions revenue saw an impressive growth of 86% to $67 million [4] - Adjusted gross margin, excluding stock-based compensation and intangibles amortization, was 63.3%, up 20 basis points year-over-year [4] Outlook - The company raised its fiscal year sales outlook to between $2.65 billion and $2.73 billion, compared to the previous range of $2.6 billion to $2.7 billion, aligning closely with the $2.66 billion estimate [3]
Hims & Hers stock falls 10% on revenue miss
CNBC· 2025-08-04 20:53
Core Insights - Hims & Hers Health reported a 73% increase in revenue for the second quarter, reaching $544.8 million compared to $315.6 million in the same period last year [1] - The company experienced a net income of $42.5 million, or 17 cents per share, up from $13.3 million, or 6 cents per share, year-over-year [1] - Despite strong year-over-year growth, the company's second-quarter results fell short of Wall Street's revenue expectations, leading to a 9% decline in shares during extended trading [1] Revenue Expectations - For the third quarter, Hims & Hers anticipates revenue between $570 million to $590 million, slightly below analysts' expectations of $583 million [2] - The adjusted EBITDA for the upcoming quarter is projected to be between $60 million to $70 million, while analysts had expected $77.1 million [2] Earnings Comparison - The adjusted earnings per share for the second quarter were reported at 17 cents, compared to an expectation of 15 cents [3] - Revenue for the second quarter was reported at $544.8 million, which was slightly below the expected $552 million [3]
Shareholders who lost money on Sable Offshore Corp. (NYSE: SOC) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 26th
Prnewswire· 2025-08-04 20:53
Core Viewpoint - A class action lawsuit has been filed against Sable Offshore Corp. for allegedly making false statements regarding its oil production activities, leading to investor damages during the specified class period [1][2]. Group 1: Lawsuit Details - The lawsuit was filed on behalf of purchasers of Sable Offshore Corp. securities between May 19, 2025, and June 3, 2025, and/or related to the company's secondary public offering on May 21, 2025 [1]. - Defendants allegedly misrepresented that Sable Offshore Corp. had restarted oil production off the coast of California when it had not, resulting in materially false and misleading statements about the company's business and prospects [2]. Group 2: Legal Representation - Wolf Haldenstein Adler Freeman & Herz LLP, a law firm with over 125 years of experience in securities litigation, is representing the investors in this case [4]. - The firm encourages affected investors to contact them for assistance and to join the lawsuit [5].
LINEAGE, INC. (NASDAQ: LINE) INVESTOR ALERT – Investors With Large Losses in Lineage, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
GlobeNewswire News Room· 2025-08-04 20:50
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) in, or traceable to, the registration statement issued in connection with the Company’s July 2024 initial public offering (the “IPO”). For more information, submit a form at Lineage, Inc. Shareholder Class Action Lawsuit, email Inv ...
Vimeo (VMEO) Q2 EPS Beats by 1,500%
The Motley Fool· 2025-08-04 20:49
Vimeo (VMEO 4.25%) is a video software platform enabling businesses and creators to make, manage, and distribute professional videos without advertising. On August 4, 2025, the company reported its Q2 2025 earnings results. The main headlines: GAAP earnings per share (EPS) of $0.04 easily beat analyst forecasts by $0.0375, or 1500%. However, GAAP revenue came in at $104.65 million, just under the consensus estimate of $105.76 million and nearly flat with the same period last year. Management raised its adju ...
Tactile Systems (TCMD) Q2 Revenue Up 8%
The Motley Fool· 2025-08-04 20:47
Tactile Systems Technology (TCMD 2.49%), a medical technology company focused on chronic disease therapy devices, posted its financial results for the second quarter of fiscal 2025 on August 4, 2025. The standout result from the release was stronger-than-expected revenue, which exceeded analyst estimates for Q2 2025 (GAAP), led by impressive gains in the airway clearance business. GAAP revenue was $78.9 million in Q2 2025, ahead of the $73.9 million GAAP consensus estimate, and diluted earnings per share (G ...